Id |
Subject |
Object |
Predicate |
Lexical cue |
T113 |
0-97 |
Sentence |
denotes |
Table 1 Screening for inhibitory activity of sinefungin and compounds 1–16 at 50 μM on N7-MTases. |
T114 |
98-146 |
Sentence |
denotes |
Compounds Percentage of inhibition at 50 μM (%)a |
T115 |
147-188 |
Sentence |
denotes |
SARS-CoV nsp14 Vaccinia virusD1-D12 hRNMT |
T116 |
189-232 |
Sentence |
denotes |
Sinefungin 98.3 ± 0.2 99.8 ± 0.1 99.8 ± 0.2 |
T117 |
233-267 |
Sentence |
denotes |
1 31.0 ± 6.8 20.3 ± 0.8 35.2 ± 4.9 |
T118 |
268-302 |
Sentence |
denotes |
2 72.0 ± 1.2 85.8 ± 2.5 77.4 ± 1.2 |
T119 |
303-337 |
Sentence |
denotes |
3 30.6 ± 9.3 32.1 ± 2.4 33.2 ± 4.3 |
T120 |
338-373 |
Sentence |
denotes |
4 13.1 ± 13.3 53.2 ± 2.6 12.2 ± 2.1 |
T121 |
374-394 |
Sentence |
denotes |
5 n.i n.i 27.5 ± 6.6 |
T122 |
395-430 |
Sentence |
denotes |
6 38.4 ± 11.7 11.6 ± 7.1 23.1 ± 9.7 |
T123 |
431-459 |
Sentence |
denotes |
7 n.i 69.2 ± 1.9 32.8 ± 16.1 |
T124 |
460-480 |
Sentence |
denotes |
8 43.0 ± 4.0 n.i n.i |
T125 |
481-515 |
Sentence |
denotes |
9 88.6 ± 1.3 49.8 ± 3.2 66.0 ± 6.1 |
T126 |
516-550 |
Sentence |
denotes |
10 96.6 ± 0.9 4.6 ± 0.3 31.8 ± 3.3 |
T127 |
551-585 |
Sentence |
denotes |
11 47.6 ± 2.8 5.3 ± 4.3 44.2 ± 8.5 |
T128 |
586-621 |
Sentence |
denotes |
12 94.6 ± 1.1 10.1 ± 5.5 23.3 ± 3.6 |
T129 |
622-656 |
Sentence |
denotes |
13 97.2 ± 2.7 2.8 ± 0.8 33.9 ± 3.3 |
T130 |
657-692 |
Sentence |
denotes |
14 96.2 ± 1.5 19.7 ± 3.8 20.2 ± 9.4 |
T131 |
693-720 |
Sentence |
denotes |
15 94.0 ± 1.1 4.3 ± 3.9 n.i |
T132 |
721-756 |
Sentence |
denotes |
16 75.9 ± 2.5 4.5 ± 15.1 14.7 ± 1.3 |
T133 |
757-811 |
Sentence |
denotes |
aValues are the mean of three independent experiments. |
T134 |
812-873 |
Sentence |
denotes |
The MTase activity was measured using a filter binding assay. |
T135 |
874-1065 |
Sentence |
denotes |
Assays were carried out in reaction mixture [40 mM Tris-HCl (pH 8.0), 1 mM DTT, 1 mM MgCl2, 2 μM SAM and 0.1 μM 3H-SAM] in the presence of 0.7 μM GpppAC4 synthetic RNA and incubated at 30 °C. |
T136 |
1066-1172 |
Sentence |
denotes |
SARS-CoV nsp14 (50 nM), vaccinia virus capping enzyme (D1-D12) (41 U), human RNA N7 MTase (hRNMT) (50 nM). |
T137 |
1173-1260 |
Sentence |
denotes |
Compounds were previously dissolved in 100% DMSO. n.i: no inhibition detected at 50 μM. |